BIOMAE

BIOMAE is a biotech company in Château-Gaillard, France, founded in 2014.

BIOMAE, tester la qualité de l'eau à l'aide de gammares

Headquarters
Château-Gaillard
Founded
2014
Business Model
B2B
Website
biomae.fr

About

BIOMAE is a French biosurveillance company based in Château-Gaillard that raises Gammarus (freshwater shrimp) as sentinel organisms to monitor water and aquatic environment quality for industrial and public water managers. Founded in 2014 as a spin-off of Irstea's ecotoxicology laboratory, the company offers AFNOR-standardized bioaccumulation and ecotoxicity bioassays used by France's six water agencies to track pollutant impact under the EU Water Framework Directive. BIOMAE is part of the CARSO Group.

Tech & App Stack

6 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Similar Companies

Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026
Isomorphic Labs

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

London, United Kingdom201–500Artificial Intelligence, Biotech
Series BTotal funding$2.6BMay 2026
AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Calico

Calico researches human aging using advanced technologies and model systems, applying that knowle...

South San Francisco, United States201–500Biotech, Healthcare
Corporate RoundTotal funding$2.3BJun 2018
Sana BiotechnologyIPO

Developer of engineered cells as medicines to treat diseases by repairing or replacing cells for ...

Seattle, United States201–500Biotech, Healthcare
Series DTotal funding$1.4BJun 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

BIOMAE on Indexed.vc
<a href="https://indexed.vc/companies/biomae"><img src="https://indexed.vc/api/badge/company/biomae" alt="BIOMAE on Indexed.vc" width="260" height="76" /></a>